AIP
BCAB icon

Ameritas Investment Partners’s BioAtla BCAB Stock Holding History

Ameritas Investment Partners’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73
Closed -$12.6K – 3133
2024
Q1 		$12.6K Hold
73
– – ﹤0.01% 2754
2023
Q4 		$8.99K Hold
73
– – ﹤0.01% 2870
2023
Q3 		$6.21K Hold
73
– – ﹤0.01% 2948
2023
Q2 		$11K Buy
+73
New +$12.6K ﹤0.01% 2876
2022
Q2 		– Sell
-24
Closed -$6K – 3077
2022
Q1 		$6K Hold
24
– – ﹤0.01% 2919
2021
Q4 		$23K Hold
24
– – ﹤0.01% 2570
2021
Q3 		$35K Buy
24
+5
+26% +$9.74K ﹤0.01% 2374
2021
Q2 		$40K Hold
19
– – ﹤0.01% 2326
2021
Q1 		$48K Buy
+19
New +$48.7K ﹤0.01% 2103

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Ameritas Investment Partners's BCAB Position: Q2 2024 in Review

Ameritas Investment Partners sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 73 shares — an estimated $12.6K sold.

Ameritas Investment Partners first reported a position in BCAB in Q1 2021 and held it in 9 quarters. The position peaked at $48K in Q1 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Ameritas Investment Partners reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 73 BioAtla shares in Q2 2024, an estimated $12.6K.
  • Ameritas Investment Partners first reported a position in BioAtla in Q1 2021 and held it in 9 quarters.
  • Ameritas Investment Partners's BioAtla position peaked at $48K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.